Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1 fusion gene generation as a consequence of the t(9;22)(q34;q11) rearrangement. The identification of the BCR-ABL1 transcript was of critical importance for both CML diagnosis and minimal residual disease (MRD) mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cumbo, Cosimo, Anelli, Luisa, Specchia, Giorgina, Albano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211966/
https://www.ncbi.nlm.nih.gov/pubmed/32440215
http://dx.doi.org/10.2147/CMAR.S232752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211966/
https://www.ncbi.nlm.nih.gov/pubmed/32440215
http://dx.doi.org/10.2147/CMAR.S232752

Ejemplares similares